MedTrace Logo

A Study of the Sleepnet Elara APAP Device

NCT07559708 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-04-30

No results posted yet for this study

Summary

The goal of this study is to evaluate the effectiveness of the Elara APAP device.

Conditions

  • Sleep Apnea - Obstructive

Interventions

DEVICE

Sleepnet Elara Treatment

Subject to have a 1 night in-lab PSG

Sponsors & Collaborators

  • Sleepnet Corporation

    lead INDUSTRY

Principal Investigators

  • Anthony McLeod, MD · University Sleep Disorders Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-27
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07559708 on ClinicalTrials.gov